These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18991323)

  • 1. Automated compound verification using 2D-NMR HSQC data in an open-access environment.
    Keyes P; Hernandez G; Cianchetta G; Robinson J; Lefebvre B
    Magn Reson Chem; 2009 Jan; 47(1):38-52. PubMed ID: 18991323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC-SPE-NMR in pharmaceutical development: capabilities and applications.
    Sandvoss M; Bardsley B; Beck TL; Lee-Smith E; North SE; Moore PJ; Edwards AJ; Smith RJ
    Magn Reson Chem; 2005 Sep; 43(9):762-70. PubMed ID: 16049946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein recycling system for nuclear magnetic resonance-based screening of drug candidates.
    Hirayama A; Shirota O; Nomura M; Nagadoi A; Nishimura Y
    Anal Biochem; 2006 Jun; 353(1):99-107. PubMed ID: 16626618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists.
    LaPlante SR; Carson R; Gillard J; Aubry N; Coulombe R; Bordeleau S; Bonneau P; Little M; O'Meara J; Beaulieu PL
    J Med Chem; 2013 Jun; 56(12):5142-50. PubMed ID: 23730910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic analysis of quantitative NMR data of pharmaceutical compound libraries.
    Liu X; Kolpak MX; Wu J; Leo GC
    Anal Chem; 2012 Aug; 84(15):6914-8. PubMed ID: 22793685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of an on-line semi-preparative LC-SPE-NMR system for trace analysis.
    Xu F; Alexander AJ
    Magn Reson Chem; 2005 Sep; 43(9):776-82. PubMed ID: 16049948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Hadamard spectroscopy to automated structure verification in high-throughput NMR.
    Ruan K; Yang S; Van Sant KA; Likos JJ
    Magn Reson Chem; 2009 Aug; 47(8):693-700. PubMed ID: 19496061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and implementation of an automated compound management system in support of lead optimization.
    Quintero C; Kariv I
    J Biomol Screen; 2009 Jun; 14(5):499-508. PubMed ID: 19487770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operation of an academic open access mass spectrometry facility with particular reference to the analysis of synthetic compounds.
    Greaves J
    J Mass Spectrom; 2002 Aug; 37(8):777-85. PubMed ID: 12203671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-access high-resolution mass spectrometry in early drug discovery.
    Thomas SR; Gerhard U
    J Mass Spectrom; 2004 Aug; 39(8):942-8. PubMed ID: 15329846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity- and gradient-enhanced heteronuclear coupled/decoupled HSQC-TOCSY experiments for measuring long-range heteronuclear coupling constants.
    Kövér KE; Hruby VJ; Uhrín D
    J Magn Reson; 1997 Dec; 129(2):125-9. PubMed ID: 9441876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and novel discrimination and quantification of oleanolic and ursolic acids in complex plant extracts using two-dimensional nuclear magnetic resonance spectroscopy-Comparison with HPLC methods.
    Kontogianni VG; Exarchou V; Troganis A; Gerothanassis IP
    Anal Chim Acta; 2009 Mar; 635(2):188-95. PubMed ID: 19216877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic compatibility tests of HSQC NMR spectra with proposed structures of chemical compounds.
    Bodis L; Ross A; Bodis J; Pretsch E
    Talanta; 2009 Oct; 79(5):1379-86. PubMed ID: 19635374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in high-throughput mass spectrometry.
    Morand KL; Burt TM; Regg BT; Tirey DA
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):729-35. PubMed ID: 11899612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of a rapid automated solubility classification into early validation of hits obtained by high throughput screening.
    Fligge TA; Schuler A
    J Pharm Biomed Anal; 2006 Oct; 42(4):449-54. PubMed ID: 16797909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using indirect covariance spectra to identify artifact responses in unsymmetrical indirect covariance calculated spectra.
    Martin GE; Hilton BD; Blinov KA; Williams AJ
    Magn Reson Chem; 2008 Feb; 46(2):138-43. PubMed ID: 18098170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated open-access liquid chromatography high resolution mass spectrometry to support drug discovery projects.
    Fontana A; Iturrino L; Corens D; Crego AL
    J Pharm Biomed Anal; 2020 Jan; 178():112908. PubMed ID: 31610393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of unsymmetrical indirect covariance NMR methods to the computation of the (13)C <--> (15)N HSQC-IMPEACH and (13)C <--> (15)N HMBC-IMPEACH correlation spectra.
    Martin GE; Hilton BD; Irish PA; Blinov KA; Williams AJ
    Magn Reson Chem; 2007 Oct; 45(10):883-8. PubMed ID: 17729230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated structure verification based on a combination of 1D (1)H NMR and 2D (1)H - (13)C HSQC spectra.
    Golotvin SS; Vodopianov E; Pol R; Lefebvre BA; Williams AJ; Rutkowske RD; Spitzer TD
    Magn Reson Chem; 2007 Oct; 45(10):803-13. PubMed ID: 17694570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching.
    Gros M; Petrović M; Barceló D
    Anal Chem; 2009 Feb; 81(3):898-912. PubMed ID: 19113952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.